Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 8/2017

01-08-2017 | Original Article – Cancer Research

Undertreatment trend in elderly lung cancer patients in Brazil

Authors: Guilherme Jorge Costa, Maria Júlia Gonçalves de Mello, Carlos Gil Ferreira, Luiz Claudio Santos Thuler

Published in: Journal of Cancer Research and Clinical Oncology | Issue 8/2017

Login to get access

Abstract

Purpose

Elderly patients with lung cancer tend to be undertreated in comparison to younger patients. The objective of this study is to compare treatment modalities offered to lung cancer patients from 70 years of age or more with patients under 70.

Methods

For this study, an analytical cross-sectional epidemiological study conducted with data from the Brazilian hospital-based cancer registries between the years 2000 and 2011. In addition, odds ratios (OR) were calculated, with a 95% confidence intervals (95% CI), in conjunction with the construction of a logistic regression model.

Results

By analyzing the records of 40,403 patients with lung cancer, we found that overall, patients from 70 years of age or more corresponded to 28.6% of the study population. Squamous cell carcinoma was the most common histological type among patients ≥70 years of age, whereas adenocarcinoma was the more prevalent type among younger patients. In comparison to younger patients, the older ones were treated less often (OR = 0.57; 95% CI: 0.52–0.62). Moreover, older patients were less likely to undergo surgery (OR = 0.69; 95% CI: 0.64–0.75), radiotherapy (OR = 0.86; 95% CI: 0.81–0.92), chemotherapy (OR = 0.61; 95% CI: 0.57–0.64), or an association of two or more treatment modalities (OR = 0.58; 95% CI: 0.54–0.62).

Conclusion

The study finds that Brazilian lung cancer patients ≥70 years of age are often undertreated and higher percentage of early death rates as compared to patients under 70. In regard to treatment, age alone should not determine whether patients with lung cancer are treated or not.
Literature
go back to reference Alberg AJ et al (2013) Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e1S–29SCrossRefPubMedPubMedCentral Alberg AJ et al (2013) Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e1S–29SCrossRefPubMedPubMedCentral
go back to reference Barrett K, Pierre A, Leighl N, Brade A (2011) Treatment of the elderly when cure is the goal the influence of age on treatment selection and efficacy for stage III. J Thorac Oncol 6(3):537–544CrossRefPubMed Barrett K, Pierre A, Leighl N, Brade A (2011) Treatment of the elderly when cure is the goal the influence of age on treatment selection and efficacy for stage III. J Thorac Oncol 6(3):537–544CrossRefPubMed
go back to reference Blanco R et al (2014) A review of the management of elderly patients with non-small-cell lung cancer. Ann Oncol 2014:1–13 Blanco R et al (2014) A review of the management of elderly patients with non-small-cell lung cancer. Ann Oncol 2014:1–13
go back to reference Brunello A et al (2009) Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool. Cancer Treat Rev 35(6):487–492CrossRefPubMed Brunello A et al (2009) Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool. Cancer Treat Rev 35(6):487–492CrossRefPubMed
go back to reference Costa GJ et al (2006) Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Lung Cancer 53(2):171–176CrossRefPubMed Costa GJ et al (2006) Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Lung Cancer 53(2):171–176CrossRefPubMed
go back to reference Costa GJ et al (2016) Epidemiological chances in the histological subtypes of non-small-cell lung cancer in Brazil: na analysis of 35,018 cases. Lung Cancer 97(2016):66–72CrossRefPubMed Costa GJ et al (2016) Epidemiological chances in the histological subtypes of non-small-cell lung cancer in Brazil: na analysis of 35,018 cases. Lung Cancer 97(2016):66–72CrossRefPubMed
go back to reference Cote ML, Kardia SLR, Wenzlaff AS, Land SJ, Schwartz AG (2005) Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Carcinogenesis 26(4):811–819CrossRefPubMed Cote ML, Kardia SLR, Wenzlaff AS, Land SJ, Schwartz AG (2005) Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Carcinogenesis 26(4):811–819CrossRefPubMed
go back to reference Davidoff AJ et al (2011) Chemotherapy and survival benefit in elderly patients with advanced non–small-cell lung cancer. J Clin Oncol 28(13):2191–2197CrossRef Davidoff AJ et al (2011) Chemotherapy and survival benefit in elderly patients with advanced non–small-cell lung cancer. J Clin Oncol 28(13):2191–2197CrossRef
go back to reference Foster JA et al (2010) How does older age influence oncologists’ cancer management? Oncologist 2010(15):584–592CrossRef Foster JA et al (2010) How does older age influence oncologists’ cancer management? Oncologist 2010(15):584–592CrossRef
go back to reference Gajra A et al (2014) Non–small-cell lung cancer in elderly patients: a discussion of treatment options. J Clin Oncol 32(24):2562–2569CrossRefPubMed Gajra A et al (2014) Non–small-cell lung cancer in elderly patients: a discussion of treatment options. J Clin Oncol 32(24):2562–2569CrossRefPubMed
go back to reference Gironés R et al (2011) Lung cancer prognostic impact of comorbidity in elderly lung cancer patients: use and comparison of two scores. Lung Cancer 2011(72):108–113CrossRef Gironés R et al (2011) Lung cancer prognostic impact of comorbidity in elderly lung cancer patients: use and comparison of two scores. Lung Cancer 2011(72):108–113CrossRef
go back to reference Gridelli C, Maione P, Rossi A, Palazzolo G, Colantuoni G, Rossi E (2009) Management of unfit older patients with advanced NSCLC. Cancer Treat Rev 35(6):517–521CrossRefPubMed Gridelli C, Maione P, Rossi A, Palazzolo G, Colantuoni G, Rossi E (2009) Management of unfit older patients with advanced NSCLC. Cancer Treat Rev 35(6):517–521CrossRefPubMed
go back to reference Gridelli C, Balducci L, Ciardiello F et al (2015) Treatment of elderly patients with non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncology. Clin Lung Cancer 16(5):325–333CrossRefPubMed Gridelli C, Balducci L, Ciardiello F et al (2015) Treatment of elderly patients with non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncology. Clin Lung Cancer 16(5):325–333CrossRefPubMed
go back to reference Howlader N, Noone AM, Krapcho M et al (2013) SEER cancer statistics review, 1975–2010. National Cancer Institute, Bethesda Howlader N, Noone AM, Krapcho M et al (2013) SEER cancer statistics review, 1975–2010. National Cancer Institute, Bethesda
go back to reference Hutchins LF et al (1999) Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med 1999(341):2061–2067CrossRef Hutchins LF et al (1999) Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med 1999(341):2061–2067CrossRef
go back to reference Kawaguchi T et al (2012) Chemotherapy is beneficial for elderly patients with advanced non–small-cell lung cancer: analysis of patients aged 70–74, 75–79, and 80 or older in Japan. Clin Lung Cancer 13:442–447CrossRefPubMed Kawaguchi T et al (2012) Chemotherapy is beneficial for elderly patients with advanced non–small-cell lung cancer: analysis of patients aged 70–74, 75–79, and 80 or older in Japan. Clin Lung Cancer 13:442–447CrossRefPubMed
go back to reference Langer CJ (2011) Clinical evidence on the undertreatment of older and poor performance patients who have advanced non-small-cell lung cancer: is there a role for targeted therapy in these cohorts? Clin Lung Cancer 12(5):272–279CrossRefPubMed Langer CJ (2011) Clinical evidence on the undertreatment of older and poor performance patients who have advanced non-small-cell lung cancer: is there a role for targeted therapy in these cohorts? Clin Lung Cancer 12(5):272–279CrossRefPubMed
go back to reference Lortet-tieulent J et al (2014) Lung cancer international trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer 84(1):13–22CrossRefPubMed Lortet-tieulent J et al (2014) Lung cancer international trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer 84(1):13–22CrossRefPubMed
go back to reference Moura MADS et al (2014) The magnitude of the association between smoking and the risk of developing cancer in Brazil: a multicenter study. BMJ Open 4(2):1–8CrossRef Moura MADS et al (2014) The magnitude of the association between smoking and the risk of developing cancer in Brazil: a multicenter study. BMJ Open 4(2):1–8CrossRef
go back to reference Ng R et al (2005) Undertreatment of elderly patients with non-small-cell lung cancer. Clin Lung Cancer 7(3):168–174CrossRefPubMed Ng R et al (2005) Undertreatment of elderly patients with non-small-cell lung cancer. Clin Lung Cancer 7(3):168–174CrossRefPubMed
go back to reference Owonikoko TK et al (2007) Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 25(35):5570–5577CrossRefPubMed Owonikoko TK et al (2007) Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 25(35):5570–5577CrossRefPubMed
go back to reference Pallis AG et al (2010) Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer? Cancer Treat Rev 36(5):436–441CrossRefPubMed Pallis AG et al (2010) Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer? Cancer Treat Rev 36(5):436–441CrossRefPubMed
go back to reference Pallis AG et al (2011) Are we treating enough elderly patients with early stage non-small cell lung cancer? Lung Cancer 74(2):149–154CrossRefPubMed Pallis AG et al (2011) Are we treating enough elderly patients with early stage non-small cell lung cancer? Lung Cancer 74(2):149–154CrossRefPubMed
go back to reference Pallis AG et al (2014) Management of elderly patients with NSCLC; updated expert’s opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. Ann Oncol 2014(25):1270–1283CrossRef Pallis AG et al (2014) Management of elderly patients with NSCLC; updated expert’s opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. Ann Oncol 2014(25):1270–1283CrossRef
go back to reference Smith BD et al (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765CrossRefPubMed Smith BD et al (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765CrossRefPubMed
go back to reference Subramanian R et al (2010) Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young. J Thorac Oncol 5(1):23–28CrossRefPubMed Subramanian R et al (2010) Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young. J Thorac Oncol 5(1):23–28CrossRefPubMed
go back to reference Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC (2012) Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol 30(13):1447–1455CrossRefPubMedPubMedCentral Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC (2012) Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol 30(13):1447–1455CrossRefPubMedPubMedCentral
Metadata
Title
Undertreatment trend in elderly lung cancer patients in Brazil
Authors
Guilherme Jorge Costa
Maria Júlia Gonçalves de Mello
Carlos Gil Ferreira
Luiz Claudio Santos Thuler
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 8/2017
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2412-8

Other articles of this Issue 8/2017

Journal of Cancer Research and Clinical Oncology 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.